{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "31026161", "DateCompleted": {"Year": "2020", "Month": "06", "Day": "22"}, "DateRevised": {"Year": "2020", "Month": "06", "Day": "22"}, "Article": {"ArticleDate": [{"Year": "2019", "Month": "04", "Day": "26"}], "Language": ["eng"], "ELocationID": ["10.1021/acs.jmedchem.9b00246"], "Journal": {"ISSN": "1520-4804", "JournalIssue": {"Volume": "62", "Issue": "18", "PubDate": {"Year": "2019", "Month": "Sep", "Day": "26"}}, "Title": "Journal of medicinal chemistry", "ISOAbbreviation": "J Med Chem"}, "ArticleTitle": "Fixing the Unfixable: The Art of Optimizing Natural Products for Human Medicine.", "Pagination": {"StartPage": "8412", "EndPage": "8428", "MedlinePgn": "8412-8428"}, "Abstract": {"AbstractText": ["Molecules isolated from natural sources including bacteria, fungi, and plants are a long-standing source of therapeutics that continue to add to our medicinal arsenal today. Despite their potency and prominence in the clinic, complex natural products often exhibit a number of liabilities that hinder their development as therapeutics, which may be partially responsible for the current trend away from natural product discovery, research, and development. However, advances in synthetic biology and organic synthesis have inspired a new generation of natural product chemists to tackle powerful undeveloped scaffolds. In this Perspective, we will present case studies demonstrating the historical and current focus on making targeted, but significant, changes to natural product scaffolds via biosynthetic gene cluster manipulation, total synthesis, semisynthesis, or a combination of these methods, with a focus on increasing activity, decreasing toxicity, or improving chemical and pharmacological properties."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry , Vanderbilt University , Nashville , Tennessee 37235 , United States."}], "LastName": "Y\u00f1igez-Gutierrez", "ForeName": "Audrey E", "Initials": "AE"}, {"Identifier": ["0000-0001-5815-1176"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry , Vanderbilt University , Nashville , Tennessee 37235 , United States."}], "LastName": "Bachmann", "ForeName": "Brian O", "Initials": "BO"}], "GrantList": [{"GrantID": "R01 AI140400", "Acronym": "AI", "Agency": "NIAID NIH HHS", "Country": "United States"}, {"GrantID": "R01 GM092218", "Acronym": "GM", "Agency": "NIGMS NIH HHS", "Country": "United States"}, {"GrantID": "T32 GM065086", "Acronym": "GM", "Agency": "NIGMS NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, N.I.H., Extramural", "Research Support, U.S. Gov't, Non-P.H.S.", "Review"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "J Med Chem", "NlmUniqueID": "9716531", "ISSNLinking": "0022-2623"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Bacterial Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Benzoquinones"}, {"RegistryNumber": "0", "NameOfSubstance": "Biological Products"}, {"RegistryNumber": "0", "NameOfSubstance": "Glycopeptides"}, {"RegistryNumber": "0", "NameOfSubstance": "Lactams, Macrocyclic"}, {"RegistryNumber": "0", "NameOfSubstance": "Macrolides"}, {"RegistryNumber": "0", "NameOfSubstance": "Peptides"}, {"RegistryNumber": "0", "NameOfSubstance": "Polyenes"}, {"RegistryNumber": "0", "NameOfSubstance": "Tetracyclines"}, {"RegistryNumber": "23668-11-3", "NameOfSubstance": "Pactamycin"}, {"RegistryNumber": "Z3K3VJ16KU", "NameOfSubstance": "geldanamycin"}], "MeshHeadingList": [{"QualifierName": ["pharmacology"], "DescriptorName": "Anti-Bacterial Agents"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Benzoquinones"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Biological Products"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": [], "DescriptorName": "Chemistry, Organic"}, {"QualifierName": ["trends"], "DescriptorName": "Chemistry, Pharmaceutical"}, {"QualifierName": ["chemistry"], "DescriptorName": "Glycopeptides"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Lactams, Macrocyclic"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Macrolides"}, {"QualifierName": [], "DescriptorName": "Multigene Family"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Neoplasms"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Pactamycin"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Peptides"}, {"QualifierName": ["chemistry"], "DescriptorName": "Polyenes"}, {"QualifierName": ["trends"], "DescriptorName": "Synthetic Biology"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Tetracyclines"}], "CoiStatement": "The authors declare no competing financial interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Newman DJ; Cragg GM Natural products as sources of new drugs from 1981 to 2014. J. Nat. Prod 2016, 79, 629\u2013661.", "ArticleIdList": ["26852623"]}, {"Citation": "Wiley PF; Jahnke HK; MacKellar FA; Kelly RB; Argoudelis AD Structure of pactamycin. J. Org. Chem 1970, 35, 1420\u20131425.", "ArticleIdList": ["5440331"]}, {"Citation": "Tejedor F; Amils R; Ballesta JPG Pactamycin binding site on archaebacterial and eukaryotic ribosomes. Biochemistry 1987, 26, 652\u2013656."}, {"Citation": "Mankin AS; Garrett RA Chloramphenicol resistance mutations in the single 23S rRNA gene of the archaeon Halobacterium halobium. J. Bacteriol 1991, 173, 3559\u20133563.", "ArticleIdList": ["PMC207972", "2045374"]}, {"Citation": "Brodersen DE; Clemons WM; Carter AP; Morgan-Warren RJ; Wimberly BT; Ramakrishnan V The structural basis for the action of the antibiotics tetracycline, pactamycin, and hygromycin B on the 30S ribosomal subunit. Cell 2000, 103, 1143\u20131154.", "ArticleIdList": ["11163189"]}, {"Citation": "Ballesta JPG; Cundliffe E Site-specific methylation of 16S rRNA caused by pct, a pactamycin resistance determinant from the producing organism, Streptomyces pactum. J. Bacteriol 1991, 173, 7213\u20137218.", "ArticleIdList": ["PMC209227", "1657884"]}, {"Citation": "Bhuyan BK; Dietz A; Smith CG Pactamycin, a new antitumor antibiotic. I. Discovery and biological properties. Antimicrob. Agents Chemother 1962, 1961, 184\u2013190."}, {"Citation": "Weller DD; Rinehart KL Biosynthesis of the antitumor antibiotic pactamycin. A methionine-derived ethyl group and a C7N unit. J. Am. Chem. Soc 1978, 100, 6757\u20136760."}, {"Citation": "Rinehart KL Jr.; Potgieter M; Delaware DL; Seto H Direct evidence from multiple carbon-13-labeling and homonuclear decoupling for the labeling pattern by glucose of the m-aminobenzoyl (C7N) unit of pactamycin. J. Am. Chem. Soc 1981, 103, 2099\u20132101."}, {"Citation": "Adams ES; Rinehart KL Directed biosynthesis of 5\u2033-fluoropactamycin in Streptomyces pactum. J. Antibiot 1994, 47, 1456\u20131465.", "ArticleIdList": ["7844040"]}, {"Citation": "Ito T; Roongsawang N; Shirasaka N; Lu W; Flatt PM; Kasanah N; Miranda C; Mahmud T Deciphering pactamycin biosynthesis and engineered production of new pactamycin analogues. ChemBioChem 2009, 10, 2253\u20132265.", "ArticleIdList": ["19670201"]}, {"Citation": "Lu W; Roongsawang N; Mahmud T Biosynthetic studies and genetic engineering of pactamycin analogs with improved selectivity toward malarial parasites. Chem. Biol 2011, 18, 425\u2013431.", "ArticleIdList": ["21513878"]}, {"Citation": "Hirayama A; Eguchi T; Kudo F A single PLP-dependent enzyme PctV catalyzes the transformation of 3-dehydroshikimate into 3-aminobenzoate in the biosynthesis of pactamycin. ChemBioChem 2013, 14, 1198\u20131203.", "ArticleIdList": ["23744829"]}, {"Citation": "Almabruk KH; Lu W; Li Y; Abugreen M; Kelly JX; Mahmud T Mutasynthesis of fluorinated pactamycin analogues and their antimalarial activity. Org. Lett 2013, 15, 1678\u20131681.", "ArticleIdList": ["PMC3663920", "23521145"]}, {"Citation": "Abugrain ME; Lu W; Li Y; Serrill JD; Brumsted CJ; Osborn AR; Alani A; Ishmael JE; Kelly JX; Mahmud T Interrogating the tailoring steps of pactamycin biosynthesis and accessing new pactamycin analogues. ChemBioChem 2016, 17, 1585\u20131588.", "ArticleIdList": ["27305101"]}, {"Citation": "Abugrain ME; Brumsted CJ; Osborn AR; Philmus B; Mahmud T A highly promiscuous \u03b2-ketoacyl-ACP synthase (KAS) III-like protein is involved in pactamycin biosynthesis. ACS Chem. Biol 2017, 12, 362\u2013366.", "ArticleIdList": ["28060484"]}, {"Citation": "Iwatsuki M; Nishihara-Tsukashima A; Ishiyama A; Namatame M; Watanabe Y; Handasah S; Pranamuda H; Marwoto B; Matsumoto A; Takahashi Y; Otoguro K; Omura S Jogyamycin, a new antiprotozoal aminocyclopentitol antibiotic, produced by Streptomyces sp. a-WM-JG-16.2. J. Antibiot 2012, 65, 169\u2013171.", "ArticleIdList": ["22234298"]}, {"Citation": "Hanessian S; Vakiti RR; Dorich S; Banerjee S; Lecomte F; DelValle JR; Zhang J; Deschenes-Simard B Total synthesis of pactamycin. Angew. Chem., Int. Ed 2011, 50, 3497\u20133500.", "ArticleIdList": ["21370372"]}, {"Citation": "Hanessian S; Vakiti RR; Chattopadhyay AK; Dorich S; Lavallee C Probing functional diversity in pactamycin toward antibiotic, antitumor, and antiprotozoal activity. Bioorg. Med. Chem 2013, 21, 1775\u20131786.", "ArticleIdList": ["23434136"]}, {"Citation": "Sharpe RJ; Malinowski JT; Sorana F; Luft JC; Bowerman CJ; DeSimone JM; Johnson JS Preparation and biological evaluation of synthetic and polymer-encapsulated congeners of the antitumor agent pactamycin: Insight into functional group effects and biological activity. Bioorg. Med. Chem 2015, 23, 1849\u20131857.", "ArticleIdList": ["PMC4380168", "25792144"]}, {"Citation": "Denning DW; Hope WW Therapy for fungal diseases: Opportunities and priorities. Trends Microbiol. 2010, 18, 195\u2013204.", "ArticleIdList": ["20207544"]}, {"Citation": "Jambor WP; Steinberg BA; Suydam LO Amphotericins A and B: Two new antifungal antibiotics possessing high activity against deep-seated and superficial mycoses. Antibiot. Annu 1955, 3, 574\u2013578.", "ArticleIdList": ["13355329"]}, {"Citation": "Dutcher JD The discovery and development of amphotericin B. Dis. Chest 1968, 54, 296\u2013298.", "ArticleIdList": ["4877964"]}, {"Citation": "Sawaya BP; Briggs JP; Schnermann J Amphotericin B nephrotoxicity: The adverse consequences of altered membrane properties. J. Am. Soc. Nephrol 1995, 6, 154\u2013164.", "ArticleIdList": ["7579079"]}, {"Citation": "Hartsel SC; Hatch C; Ayenew W How does amphotericin B work?: Studies on model membrane systems. J. Liposome Res 1993, 3, 377\u2013408."}, {"Citation": "Gray KC; Palacios DS; Dailey I; Endo MM; Uno BE; Wilcock BC; Burke MD Amphotericin primarily kills yeast by simply binding ergosterol. Proc. Natl. Acad. Sci. U. S. A 2012, 109, 2234\u20132239.", "ArticleIdList": ["PMC3289339", "22308411"]}, {"Citation": "Nicolaou KC; Daines RA; Ogawa Y; Chakraborty TK Total synthesis of amphotericin B. 3. The final stages. J. Am. Chem. Soc 1988, 110, 4696\u20134705."}, {"Citation": "Carreira EM; Cereghetti DM Amphotericin B: 50 years of chemistry and biochemistry. Synthesis 2006, 914\u2013942."}, {"Citation": "Carmody M; Murphy B; Byrne B; Power P; Rai D; Rawlings B; Caffrey P Biosynthesis of amphotericin derivatives lacking exocyclic carboxyl groups. J. Biol. Chem 2005, 280, 34420\u201334426.", "ArticleIdList": ["16079135"]}, {"Citation": "Brautaset T; Sletta H; Nedal A; Borgos SEF; Degnes KF; Bakke I; Volokhan O; Sekurova ON; Treshalin ID; Mirchink EP; Dikiy A; Ellingsen TE; Zotchev SB Improved antifungal polyene macrolides via engineering of the nystatin biosynthetic genes in Streptomyces noursei. Chem. Biol 2008, 15, 1198\u20131206.", "ArticleIdList": ["19022180"]}, {"Citation": "Palacios DS; Anderson TM; Burke MD A post-PKS oxidation of the amphotericin B skeleton predicted to be critical for channel formation is not required for potent antifungal activity. J. Am. Chem. Soc 2007, 129, 13804\u201313805.", "ArticleIdList": ["PMC2547886", "17956100"]}, {"Citation": "Davis SA; Vincent BM; Endo MM; Whitesell L; Marchillo K; Andes DR; Lindquist S; Burke MD Nontoxic antimicrobials that evade drug resistance. Nat. Chem. Biol 2015, 11, 481\u2013487.", "ArticleIdList": ["PMC4472574", "26030729"]}, {"Citation": "Bruheim P; Borgos SEF; Tsan P; Sletta H; Ellingsen TE; Lancelin J-M; Zotchev SB Chemical diversity of polyene macrolides produced by Streptomyces noursei ATCC 11455 and recombinant strain ERD44 with genetically altered polyketide synthase NysC. Antimicrob. Agents Chemother 2004, 48, 4120\u20134129.", "ArticleIdList": ["PMC525400", "15504830"]}, {"Citation": "Preobrazhenskaya MN; Olsufyeva EN; Solovieva SE; Tevyashova AN; Reznikova MI; Luzikov YN; Terekhova LP; Trenin AS; Galatenko OA; Treshalin ID; Mirchink EP; Bukhman VM; Sletta H; Zotchev SB Chemical modification and biological evaluation of new semisynthetic derivatives of 28,29-didehydronystatin A1 (S44HP), a genetically engineered antifungal polyene macrolide antibiotic. J. Med. Chem 2009, 52, 189\u2013196.", "ArticleIdList": ["19055412"]}, {"Citation": "Power P; Dunne T; Murphy B; Lochlainn LN; Rai D; Borissow C; Rawlings B; Caffrey P Engineered synthesis of 7-oxoand 15-deoxy-15-oxo-amphotericins: Insights into structure-activity relationships in polyene antibiotics. Chem. Biol 2008, 15, 78\u201386.", "ArticleIdList": ["18215775"]}, {"Citation": "Brautaset T; Sletta H; Degnes KF; Sekurova ON; Bakke I; Volokhan O; Andreassen T; Ellingsen TE; Zotchev SB New nystatin-related antifungal polyene macrolides with altered polyol region generated via biosynthetic engineering of Streptomyces noursei. Appl. Environ. Microbiol 2011, 77, 6636\u20136643.", "ArticleIdList": ["PMC3187132", "21764946"]}, {"Citation": "Byrne B; Carmody M; Gibson E; Rawlings B; Caffrey P Biosynthesis of deoxyamphotericins and deoxyamphoteronolides by engineered strains of Streptomyces nodosus. Chem. Biol 2003, 10, 1215\u20131224.", "ArticleIdList": ["14700629"]}, {"Citation": "Wilcock BC; Uno BE; Bromann GL; Clark MJ; Anderson TM; Burke MD Electronic tuning of site-selectivity. Nat. Chem 2012, 4, 996\u20131003.", "ArticleIdList": ["PMC3545056", "23174979"]}, {"Citation": "Wilcock BC; Endo MM; Uno BE; Burke MD C2\u2032-OH of amphotericin B plays an important role in binding the primary sterol of human cells but not yeast cells. J. Am. Chem. Soc 2013, 135, 8488\u20138491.", "ArticleIdList": ["PMC3753100", "23718627"]}, {"Citation": "Volmer AA; Szpilman AM; Carreira EM Synthesis and biological evaluation of amphotericin B derivatives. Nat. Prod. Rep 2010, 27, 1329\u20131349.", "ArticleIdList": ["20556271"]}, {"Citation": "Preobrazhenskaya MN; Olsufyeva EN; Tevyashova AN; Printsevskaya SS; Solovieva SE; Reznikova MI; Trenin AS; Galatenko OA; Treshalin ID; Pereverzeva ER; Mirchink EP; Zotchev SB Synthesis and study of the antifungal activity of new mono- and disubstituted derivatives of a genetically engineered polyene antibiotic 28,29-didehydronystatin A1 (S44HP). J. Antibiot 2010, 63, 55\u201364.", "ArticleIdList": ["19960041"]}, {"Citation": "Zhang C; Albermann C; Fu X; Thorson JS The in vitro characterization of the iterative avermectin glycosyltransferase AveBI reveals reaction reversibility and sugar nucleotide flexibility. J. Am. Chem. Soc 2006, 128, 16420\u201316421.", "ArticleIdList": ["17177349"]}, {"Citation": "Hutchinson E; Murphy B; Dunne T; Breen C; Rawlings B; Caffrey P Redesign of polyene macrolide glycosylation: Engineered biosynthesis of 19-(o)-perosaminyl- amphoteronolide B. Chem. Biol 2010, 17, 174\u2013182.", "ArticleIdList": ["20189107"]}, {"Citation": "Kim B-G; Lee M-J; Seo J; Hwang Y-B; Lee M-Y; Han K; Sherman DH; Kim E-S Identification of functionally clustered nystatin-like biosynthetic genes in a rare actinomycetes, Pseudonocardia autotrophica. J. Ind. Microbiol. Biotechnol 2009, 36, 1425\u20131434.", "ArticleIdList": ["19697072"]}, {"Citation": "Lee M-J; Kong D; Han K; Sherman DH; Bai L; Deng Z; Lin S; Kim E-S Structural analysis and biosynthetic engineering of a solubility-improved and less-hemolytic nystatin-like polyene in Pseudonocardia autotrophica. Appl. Microbiol. Biotechnol 2012, 95, 157\u2013168.", "ArticleIdList": ["22382166"]}, {"Citation": "Rossiter SE; Fletcher MH; Wuest WM Natural products as platforms to overcome antibiotic resistance. Chem. Rev 2017, 117, 12415\u201312474.", "ArticleIdList": ["PMC5869711", "28953368"]}, {"Citation": "Liu F; Myers AG Development of a platform for the discovery and practical synthesis of new tetracycline antibiotics. Curr. Opin. Chem. Biol 2016, 32, 48\u201357.", "ArticleIdList": ["27043373"]}, {"Citation": "Benitz KF; Diermeier HF Renal toxicity of tetracycline degradation products. Exp. Biol. Med 1964, 115, 930\u2013935.", "ArticleIdList": ["14166612"]}, {"Citation": "McCormick JRD; Jensen ER; Miller PA; Doerschuk AP 6-deoxytetracyclines. Further studies on the relation between structure and antibacterial activity in the tetracycline series. J. Am. Chem. Soc 1960, 82, 3381\u20133388."}, {"Citation": "Martell MJ Jr.; Boothe JH 6-deoxytetracyclines. VII. Alkylated aminotetracyclines possessing unique antibacterial activity. J. Med. Chem 1967, 10, 44\u201346.", "ArticleIdList": ["6031702"]}, {"Citation": "Chopra I; Roberts M Tetracycline antibiotics: Mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiol. Mol. Biol. Rev 2001, 65, 232\u2013260.", "ArticleIdList": ["PMC99026", "11381101"]}, {"Citation": "Forsberg KJ; Patel S; Wencewicz TA; Dantas G The tetracycline destructases: A novel family of tetracycline-inactivating enzymes. Chem. Biol 2015, 22, 888\u2013897.", "ArticleIdList": ["PMC4515146", "26097034"]}, {"Citation": "Sum P-E; Petersen P Synthesis and structure-activity relationship of novel glycylcycline derivatives leading to the discovery of GAR-936. Bioorg. Med. Chem. Lett 1999, 9, 1459\u20131462.", "ArticleIdList": ["10360756"]}, {"Citation": "Sum PE; Lee VJ; Testa RT; Hlavka JJ; Ellestad GA; Bloom JD; Gluzman Y; Tally FP Glycylcyclines. 1. A new generation of potent antibacterial agents through modification of 9-aminotetracyclines. J. Med. Chem 1994, 37, 184\u2013188.", "ArticleIdList": ["8289194"]}, {"Citation": "Petersen PJ; Jacobus NV; Weiss WJ; Sum PE; Testa RT In vitro and in vivo antibacterial activities of a novel glycylcycline, the 9-t-butylglycylamido derivative of minocycline (GAR-936). Antimicrob. Agents Chemother 1999, 43, 738\u2013744.", "ArticleIdList": ["PMC89200", "10103174"]}, {"Citation": "Dixit D; Madduri RP; Sharma R The role of tigecycline in the treatment of infections in light of the new black box warning. Expert Rev. Anti-Infect. Ther 2014, 12, 397\u2013400.", "ArticleIdList": ["24597542"]}, {"Citation": "Barber KE; Bell AM; Wingler MJB; Wagner JL; Stover KR Omadacycline enters the ring: A new antimicrobial contender. Pharmacotherapy 2018, 38, 1194\u20131204.", "ArticleIdList": ["PMC6587716", "30290000"]}, {"Citation": "Honeyman L; Ismail M; Nelson ML; Bhatia B; Bowser TE; Chen J; Mechiche R; Ohemeng K; Verma AK; Cannon EP; Macone A; Tanaka SK; Levy S Structure-activity relationship of the aminomethylcyclines and the discovery of omadacycline. Antimicrob. Agents Chemother 2015, 59, 7044\u20137053.", "ArticleIdList": ["PMC4604364", "26349824"]}, {"Citation": "Zhanel G; Critchley I; Lin L-Y; Alvandi N Microbiological profile of sarecycline, a novel targeted spectrum tetracycline for the treatment of acne vulgaris. Antimicrob. Agents Chemother 2019, 63, No e01297\u201301218.", "ArticleIdList": ["PMC6325184", "30397052"]}, {"Citation": "Korst JJ; Johnston JD; Butler K; Bianco EJ; Conover LH; Woodward RB The total synthesis of dl-6-demethyl-6-deoxytetracycline. J. Am. Chem. Soc 1968, 90, 439\u2013457."}, {"Citation": "Tatsuta K; Yoshimoto T; Gunji H; Okado Y; Takahashi M The first total synthesis of natural (\u2212)-tetracycline. Chem. Lett 2000, 29, 646\u2013647."}, {"Citation": "Charest MG; Siegel DR; Myers AG Synthesis of (\u2212)-tetracycline. J. Am. Chem. Soc 2005, 127, 8292\u20138293.", "ArticleIdList": ["15941256"]}, {"Citation": "Charest MG; Lerner CD; Brubaker JD; Siegel DR; Myers AG A convergent enantioselective route to structurally diverse 6-deoxytetracycline antibiotics. Science 2005, 308, 395\u2013398.", "ArticleIdList": ["15831754"]}, {"Citation": "Sun C; Wang Q; Brubaker JD; Wright PM; Lerner CD; Noson K; Charest M; Siegel DR; Wang Y-M; Myers AG A robust platform for the synthesis of new tetracycline antibiotics. J. Am. Chem. Soc 2008, 130, 17913\u201317927.", "ArticleIdList": ["PMC2681267", "19053822"]}, {"Citation": "Xiao X-Y; Hunt DK; Zhou J; Clark RB; Dunwoody N; Fyfe C; Grossman TH; O\u2019Brien WJ; Plamondon L; Ronn M; Sun C; Zhang W-Y; Sutcliffe JA Fluorocyclines. 1. 7-fluoro-9-pyrrolidinoacetamido-6-demethyl-6-deoxytetracycline: A potent, broad spectrum antibacterial agent. J. Med. Chem 2012, 55, 597\u2013605.", "ArticleIdList": ["22148514"]}, {"Citation": "Zhang WY; Che Q; Crawford S; Ronn M; Dunwoody N A divergent route to eravacycline. J. Org. Chem 2017, 82, 936\u2013943.", "ArticleIdList": ["28002943"]}, {"Citation": "Mullard A 2018 FDA drug approvals. Nat. Rev. Drug Discovery 2019, 18, 85\u201389.", "ArticleIdList": ["30710142"]}, {"Citation": "De Boer C; Meulman PA; Wnuk RJ; Peterson DH Geldanamycin, a new antibiotic. J. Antibiot 1970, 23, 442\u2013447.", "ArticleIdList": ["5459626"]}, {"Citation": "Supko JG; Hickman RL; Grever MR; Malspeis L Preclinical pharmacologic evaluation of geldanamycin as an antitumor agent. Cancer Chemother. Pharmacol 1995, 36, 305\u2013315.", "ArticleIdList": ["7628050"]}, {"Citation": "Whitesell L; Mimnaugh EG; De Costa B; Myers CE; Neckers LM Inhibition of heat shock protein HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: Essential role for stress proteins in oncogenic transformation. Proc. Natl. Acad. Sci. U. S. A 1994, 91, 8324\u20138328.", "ArticleIdList": ["PMC44598", "8078881"]}, {"Citation": "Stebbins CE; Russo AA; Schneider C; Rosen N; Hartl FU; Pavletich NP Crystal structure of an HSP90-geldanamycin complex: Targeting of a protein chaperone by an antitumor agent. Cell 1997, 89, 239\u2013250.", "ArticleIdList": ["9108479"]}, {"Citation": "Kamal A; Thao L; Sensintaffar J; Zhang L; Boehm MF; Fritz LC; Burrows FJ A high-affinity conformation of HSP90 confers tumor selectivity on HSP90 inhibitors. Nature 2003, 425, 407\u2013410.", "ArticleIdList": ["14508491"]}, {"Citation": "Franke J; Eichner S; Zeilinger C; Kirschning A Targeting heat-shock-protein 90 (HSP90) by natural products: Geldanamycin, a show case in cancer therapy. Nat. Prod. Rep 2013, 30, 1299\u20131323.", "ArticleIdList": ["23934201"]}, {"Citation": "Nakata M; Osumi T; Ueno A; Kimura T; Tamai T; Tatsuta K Total synthesis of herbimycin A. Tetrahedron Lett. 1991, 32, 6015\u20136018."}, {"Citation": "Andrus MB; Meredith EL; Simmons BL; Soma Sekhar BBV; Hicken EJ Total synthesis of (+)-geldanamycin and (\u2212)-o-quinogeldanamycin with use of asymmetric anti- and syn-glycolate aldol reactions. Org. Lett 2002, 4, 3549\u20133552.", "ArticleIdList": ["12323066"]}, {"Citation": "Andrus MB; Meredith EL; Hicken EJ; Simmons BL; Glancey RR; Ma W Total synthesis of (+)-geldanamycin and (\u2212)-o-quinogeldanamycin: Asymmetric glycolate aldol reactions and biological evaluation. J. Org. Chem 2003, 68, 8162\u20138169.", "ArticleIdList": ["14535799"]}, {"Citation": "Andrus MB; Hicken EJ; Meredith EL; Simmons BL; Cannon JF Selective synthesis of the para-quinone region of geldanamycin. Org. Lett 2003, 5, 3859\u20133862.", "ArticleIdList": ["14535728"]}, {"Citation": "Qin H-L; Panek JS Total synthesis of the HSP90 inhibitor geldanamycin. Org. Lett 2008, 10, 2477\u20132479.", "ArticleIdList": ["PMC2430885", "18489177"]}, {"Citation": "Wrona IE; Gozman A; Taldone T; Chiosis G; Panek JS Synthesis of reblastatin, autolytimycin, and non-benzoquinone analogues: Potent inhibitors of heat shock protein 90. J. Org. Chem 2010, 75, 2820\u20132835.", "ArticleIdList": ["PMC2906235", "20392070"]}, {"Citation": "Andrus MB; Wong Y; Liu J; Beebe K; Neckers LM Synthesis and evaluation of 8,9-amido analogs of geldanamycin. Tetrahedron Lett. 2009, 50, 6705\u20136708."}, {"Citation": "Schnur RC; Corman ML; Gallaschun RJ; Cooper BA; Dee MF; Doty JL; Muzzi ML; Moyer JD; DiOrio CI; Barbacci EG; Miller PE; O\u2019Brian AT; Morin MJ; Foster BA; Pollack VA; Savage DM; Sloan DE; Pustilnik LR; Moyer MP Inhibition of the oncogene product p185erbB\u22122in vitro and in vivo by geldanamycin and dihydrogeldanamycin derivatives. J. Med. Chem 1995, 38, 3806\u20133812.", "ArticleIdList": ["7562911"]}, {"Citation": "Tian ZQ; Liu Y; Zhang D; Wang Z; Dong SD; Carreras CW; Zhou Y; Rastelli G; Santi DV; Myles DC Synthesis and biological activities of novel 17-aminogeldanamycin derivatives. Bioorg. Med. Chem 2004, 12, 5317\u20135329.", "ArticleIdList": ["15388159"]}, {"Citation": "Le Brazidec J-Y; Kamal A; Busch D; Thao L; Zhang L; Timony G; Grecko R; Trent K; Lough R; Salazar T; Khan S; Burrows F; Boehm MF Synthesis and biological evaluation of a new class of geldanamycin derivatives as potent inhibitors of HSP90. J. Med. Chem 2004, 47, 3865\u20133873.", "ArticleIdList": ["15239664"]}, {"Citation": "Rastelli G; Tian Z-Q; Wang Z; Myles D; Liu Y Structure-based design of 7-carbamate analogs of geldanamycin. Bioorg. Med. Chem. Lett 2005, 15, 5016\u20135021.", "ArticleIdList": ["16165354"]}, {"Citation": "Dimopoulos M-A; Mitsiades CS; Anderson KC; Richardson PG Tanespimycin as antitumor therapy. Clin. Lymphoma, Myeloma Leuk 2011, 11, 17\u201322.", "ArticleIdList": ["21454186"]}, {"Citation": "Patel K; Piagentini M; Rascher A; Tian Z-Q; Buchanan GO; Regentin R; Hu Z; Hutchinson CR; McDaniel R Engineered biosynthesis of geldanamycin analogs for HSP90 inhibition. Chem. Biol 2004, 11, 1625\u20131633.", "ArticleIdList": ["15610846"]}, {"Citation": "Buchanan GO; Regentin R; Piagentini M; Rascher A; McDaniel R; Galazzo JL; Licari PJ Production of 8-demethylgeldanamycin and 4,5-epoxy-8-demethylgeldanamycin from a recombinant strain of Streptomyces hygroscopicus. J. Nat. Prod 2005, 68, 607\u2013610.", "ArticleIdList": ["15844961"]}, {"Citation": "Eichner S; Floss HG; Sasse F; Kirschning A New, highly active nonbenzoquinone geldanamycin derivatives by using mutasynthesis. ChemBioChem 2009, 10, 1801\u20131805.", "ArticleIdList": ["19554593"]}, {"Citation": "Bu\u0142yszko I; Dr\u00e4ger G; Klenge A; Kirschning A Evaluation of the synthetic potential of an AHBA knockout mutant of the rifamycin producer Amycolatopsis mediterranei. Chem. - Eur. J 2015, 21, 19231\u201319242.", "ArticleIdList": ["26559164"]}, {"Citation": "Mohammadi-Ostad-Kalayeh S; Stahl F; Scheper T; Kock K; Herrmann C; Heleno-Batista FA; Borges JC; Sasse F; Eichner S; Ongouta J; Zeilinger C; Kirschning A Heat shock proteins revisited: Using a mutasynthetically generated reblastatin library to compare the inhibition of human and Leishmania HSP90s. ChemBioChem 2018, 19, 562\u2013574.", "ArticleIdList": ["29265716"]}, {"Citation": "Kelly WL; Pan L; Li C Thiostrepton biosynthesis: Prototype for a new family of bacteriocins. J. Am. Chem. Soc 2009, 131, 4327\u20134334.", "ArticleIdList": ["19265401"]}, {"Citation": "Liao R; Duan L; Lei C; Pan H; Ding Y; Zhang Q; Chen D; Shen B; Yu Y; Liu W Thiopeptide biosynthesis featuring ribosomally synthesized precursor peptides and conserved posttranslational modifications. Chem. Biol 2009, 16, 141\u2013147.", "ArticleIdList": ["PMC2676563", "19246004"]}, {"Citation": "Bagley MC; Dale JW; Merritt EA; Xiong X Thiopeptide antibiotics. Chem. Rev 2005, 105, 685\u2013714.", "ArticleIdList": ["15700961"]}, {"Citation": "Cameron DM; Thompson J; March PE; Dahlberg AE Initiation factor IF2, thiostrepton and micrococcin prevent the binding of elongation factor G to the Escherichia coli ribosome. J. Mol. Biol 2002, 319, 27\u201335.", "ArticleIdList": ["12051934"]}, {"Citation": "Harms JM; Wilson DN; Schluenzen F; Connell SR; Stachelhaus T; Zaborowska Z; Spahn CMT; Fucini P Translational regulation via L11: Molecular switches on the ribosome turned on and off by thiostrepton and micrococcin. Mol. Cell 2008, 30, 26\u201338.", "ArticleIdList": ["18406324"]}, {"Citation": "Heffron SE; Jurnak F Structure of an EF-Tu complex with a thiazolyl peptide antibiotic determined at 2.35 \u00e5 resolution: Atomic basis for GE2270a inhibition of EF-Tu. Biochemistry 2000, 39, 37\u201345.", "ArticleIdList": ["10625477"]}, {"Citation": "Just-Baringo X; Albericio F; Alvarez M Thiopeptide engineering: A multidisciplinary effort towards future drugs. Angew. Chem., Int. Ed 2014, 53, 6602\u20136616.", "ArticleIdList": ["24861213"]}, {"Citation": "Pagano JF; Weinstein MJ; Stout HA; Donovick R Thiostrepton, a new antibiotic. I. In vitro studies. Antibiot. Annu 1956, 554\u2013559.", "ArticleIdList": ["13355325"]}, {"Citation": "Nicolaou KC; Zak M; Safina BS; Estrada AA; Lee SH; Nevalainen M Total synthesis of thiostrepton. Assembly of key building blocks and completion of the synthesis. J. Am. Chem. Soc 2005, 127, 11176\u201311183.", "ArticleIdList": ["16076225"]}, {"Citation": "Li C-X; Zhang F-F; Kelly WL Heterologous production of thiostrepton a and biosynthetic engineering of thiostrepton analogs. Mol. BioSyst 2011, 7, 82\u201390.", "ArticleIdList": ["21107477"]}, {"Citation": "Li C; Zhang F; Kelly WL Mutagenesis of the thiostrepton precursor peptide at Thr7 impacts both biosynthesis and function. Chem. Commun. (Cambridge, U. K.) 2012, 48, 558\u2013560.", "ArticleIdList": ["PMC3849712", "22068975"]}, {"Citation": "Zhang F; Kelly WL Saturation mutagenesis of TsrA Ala4 unveils a highly mutable residue of thiostrepton A. ACS Chem. Biol 2015, 10, 998\u20131009.", "ArticleIdList": ["PMC4826033", "25572285"]}, {"Citation": "Zhang F; Li C; Kelly WL Thiostrepton variants containing a contracted quinaldic acid macrocycle result from mutagenesis of the second residue. ACS Chem. Biol 2016, 11, 415\u2013424.", "ArticleIdList": ["PMC4847728", "26630475"]}, {"Citation": "Duan L; Wang S; Liao R; Liu W Insights into quinaldic acid moiety formation in thiostrepton biosynthesis facilitating fluorinated thiopeptide generation. Chem. Biol 2012, 19, 443\u2013448.", "ArticleIdList": ["22520750"]}, {"Citation": "Wang S; Zheng Q; Wang J; Zhao Z; Li Q; Yu Y; Wang R; Liu W Target-oriented design and biosynthesis of thiostrepton-derived thiopeptide antibiotics with improved pharmaceutical properties. Org. Chem. Front 2015, 2, 106\u2013109."}, {"Citation": "Liao R; Liu W Thiostrepton maturation involving a deesterification-amidation way to process the C-terminally methylated peptide backbone. J. Am. Chem. Soc 2011, 133, 2852\u20132855.", "ArticleIdList": ["21323347"]}, {"Citation": "Wang S; Zheng Q; Wang J; Chen D; Yu Y; Liu W Concurrent modifications of the C-terminus and side ring of thiostrepton and their synergistic effects with respect to improving antibacterial activities. Org. Chem. Front 2016, 3, 496\u2013500."}, {"Citation": "Key HM; Miller SJ Site- and stereoselective chemical editing of thiostrepton by Rh-catalyzed conjugate arylation: New analogues and collateral enantioselective synthesis of amino acids. J. Am. Chem. Soc 2017, 139, 15460\u201315466.", "ArticleIdList": ["PMC5736372", "28975793"]}, {"Citation": "Leet JE; Li W; Ax HA; Matson JA; Huang S; Huang R; Cantone JL; Drexler D; Dalterio RA; Lam KS Nocathiacins, new thiazolyl peptide antibiotics from Nocardia sp. II. Isolation, characterization, and structure determination. J. Antibiot 2003, 56, 232\u2013242.", "ArticleIdList": ["12760679"]}, {"Citation": "Sasaki T; Otani T; Matsumoto H; Unemi N; Hamada M; Takeuchi T; Hori M MJ347\u201381F4 A & B, novel antibiotics from Amycolatopsis sp.: Taxonomic characteristics, fermentation, and antimicrobial activity. J. Antibiot 1998, 51, 715\u2013721.", "ArticleIdList": ["9766463"]}, {"Citation": "Naidu BN; Sorenson ME; Zhang Y; Kim OK; Matiskella JD; Wichtowski JA; Connolly TP; Li W; Lam KS; Bronson JJ; Pucci MJ; Clark JM; Ueda Y Nocathiacin i analogues: Synthesis, in vitro and in vivo biological activity of novel semi-synthetic thiazolyl peptide antibiotics. Bioorg. Med. Chem. Lett 2004, 14, 5573\u20135577.", "ArticleIdList": ["15482927"]}, {"Citation": "Naidu BN; Sorenson ME; Bronson JJ; Pucci MJ; Clark JM; Ueda Y Synthesis, in vitro, and in vivo antibacterial activity of nocathiacin I thiol-Michael adducts. Bioorg. Med. Chem. Lett 2005, 15, 2069\u20132072.", "ArticleIdList": ["15808470"]}, {"Citation": "Naidu BN; Sorenson ME; Matiskella JD; Li W; Sausker JB; Zhang Y; Connolly TP; Lam KS; Bronson JJ; Pucci MJ; Yang H; Ueda Y Synthesis and antibacterial activity of nocathiacin I analogues. Bioorg. Med. Chem. Lett 2006, 16, 3545\u20133549.", "ArticleIdList": ["16621551"]}, {"Citation": "Wieland Brown LC; Acker MG; Clardy J; Walsh CT; Fischbach MA Thirteen posttranslational modifications convert a 14-residue peptide into the antibiotic thiocillin. Proc. Natl. Acad. Sci. U. S. A 2009, 106, 2549\u20132553.", "ArticleIdList": ["PMC2650375", "19196969"]}, {"Citation": "Bowers AA; Walsh CT; Acker MG Genetic interception and structural characterization of thiopeptide cyclization precursors from Bacillus cereus. J. Am. Chem. Soc 2010, 132, 12182\u201312184.", "ArticleIdList": ["PMC2932885", "20707374"]}, {"Citation": "Acker MG; Bowers AA; Walsh CT Generation of thiocillin variants by prepeptide gene replacement and in vivo processing by Bacillus cereus. J. Am. Chem. Soc 2009, 131, 17563\u201317565.", "ArticleIdList": ["PMC2787705", "19911780"]}, {"Citation": "Bowers AA; Acker MG; Koglin A; Walsh CT Manipulation of thiocillin variants by prepeptide gene replacement: Structure, conformation, and activity of heterocycle substitution mutants. J. Am. Chem. Soc 2010, 132, 7519\u20137527.", "ArticleIdList": ["PMC2882596", "20455532"]}, {"Citation": "Gober JG; Ghodge SV; Bogart JW; Wever WJ; Watkins RR; Brustad EM; Bowers AA P450-mediated non-natural cyclopropanation of dehydroalanine-containing thiopeptides. ACS Chem. Biol 2017, 12, 1726\u20131731.", "ArticleIdList": ["28535034"]}, {"Citation": "Fleming SR; Bartges TE; Vinogradov AA; Kirkpatrick CL; Goto Y; Suga H; Hicks LM; Bowers AA Flexizyme-enabled benchtop biosynthesis of thiopeptides. J. Am. Chem. Soc 2019, 141, 758\u2013762.", "ArticleIdList": ["PMC6642631", "30602112"]}, {"Citation": "LaMarche MJ; Leeds JA; Dzink-Fox J; Gunderson K; Krastel P; Memmert K; Patane MA; Rann EM; Schmitt E; Tiamfook S; Wang B 4-aminothiazolyl analogs of GE2270 A: Antibacterial lead finding. J. Med. Chem 2011, 54, 2517\u20132521.", "ArticleIdList": ["21405087"]}, {"Citation": "LaMarche MJ; Leeds JA; Amaral K; Brewer JT; Bushell SM; Dewhurst JM; Dzink-Fox J; Gangl E; Goldovitz J; Jain A; Mullin S; Neckermann G; Osborne C; Palestrant D; Patane MA; Rann EM; Sachdeva M; Shao J; Tiamfook S; Whitehead L; Yu D Antibacterial optimization of 4-aminothiazolyl analogues of the natural product GE2270 A: Identification of the cycloalkylcarboxylic acids. J. Med. Chem 2011, 54, 8099\u20138109.", "ArticleIdList": ["21999529"]}, {"Citation": "LaMarche MJ; Leeds JA; Amaral A; Brewer JT; Bushell SM; Deng G; Dewhurst JM; Ding J; Dzink-Fox J; Gamber G; Jain A; Lee K; Lee L; Lister T; McKenney D; Mullin S; Osborne C; Palestrant D; Patane MA; Rann EM; Sachdeva M; Shao J; Tiamfook S; Trzasko A; Whitehead L; Yifru A; Yu D; Yan W; Zhu Q Discovery of LFF571: An investigational agent for Clostridium difficile infection. J. Med. Chem 2012, 55, 2376\u20132387.", "ArticleIdList": ["22315981"]}, {"Citation": "Mullane K; Lee C; Bressler A; Buitrago M; Weiss K; Dabovic K; Praestgaard J; Leeds JA; Blais J; Pertel P Multicenter, randomized clinical trial to compare the safety and efficacy of LFF571 and vancomycin for Clostridium difficile infections. Antimicrob. Agents Chemother 2015, 59, 1435\u20131440.", "ArticleIdList": ["PMC4325808", "25534727"]}, {"Citation": "Bright GM; Nagel AA; Bordner J; Desai KA; Dibrino JN; Nowakowska J; Vincent L; Watrous RM; Sciavolino FC; et al. Synthesis, in vitro and in vivo activity of novel 9-deoxo-9a-aza-9a-homoerythromycin a derivatives; a new class of macrolide antibiotics, the azalides. J. Antibiot 1988, 41, 1029\u20131047.", "ArticleIdList": ["3139603"]}, {"Citation": "Fernandes P; Martens E; Bertrand D; Pereira D The solithromycin journey-it is all in the chemistry. Bioorg. Med. Chem 2016, 24, 6420\u20136428.", "ArticleIdList": ["27595539"]}, {"Citation": "Khosla C Harnessing the biosynthetic potential of modular polyketide synthases. Chem. Rev 1997, 97, 2577\u20132590.", "ArticleIdList": ["11851472"]}, {"Citation": "Park SR; Han AR; Ban Y-H; Yoo YJ; Kim EJ; Yoon YJ Genetic engineering of macrolide biosynthesis: Past advances, current state, and future prospects. Appl. Microbiol. Biotechnol 2010, 85, 1227\u20131239.", "ArticleIdList": ["19902203"]}, {"Citation": "Glassford I; Teijaro CN; Daher SS; Weil A; Small MC; Redhu SK; Colussi DJ; Jacobson MA; Childers WE; Buttaro B; Nicholson AW; MacKerell AD Jr.; Cooperman BS; Andrade RB Ribosome-templated azide-alkyne cycloadditions: Synthesis of potent macrolide antibiotics by in situ click chemistry. J. Am. Chem. Soc 2016, 138, 3136\u20133144.", "ArticleIdList": ["PMC4785600", "26878192"]}, {"Citation": "Jin X; Daher SS; Lee M; Buttaro B; Andrade RB Ribosome-templated azide-alkyne cycloadditions using resistant bacteria as reaction vessels: In cellulo click chemistry. ACS Med. Chem. Lett 2018, 9, 907\u2013911.", "ArticleIdList": ["PMC6142060", "30258539"]}, {"Citation": "Seiple IB; Zhang Z; Jakubec P; Langlois-Mercier A; Wright PM; Hog DT; Yabu K; Allu SR; Fukuzaki T; Carlsen PN; Kitamura Y; Zhou X; Condakes ML; Szczypinski FT; Green WD; Myers AG A platform for the discovery of new macrolide antibiotics. Nature 2016, 533, 338\u2013345.", "ArticleIdList": ["PMC6526944", "27193679"]}, {"Citation": "Hogan PC; Chen C-L; Mulvihill KM; Lawrence JF; Moorhead E; Rickmeier J; Myers AG Large-scale preparation of key building blocks for the manufacture of fully synthetic macrolide antibiotics. J. Antibiot 2018, 71, 318\u2013325.", "ArticleIdList": ["29018266"]}, {"Citation": "Blaskovich MAT; Hansford KA; Butler MS; Jia Z; Mark AE; Cooper MA Developments in glycopeptide antibiotics. ACS Infect. Dis 2018, 4, 715\u2013735.", "ArticleIdList": ["PMC5952257", "29363950"]}, {"Citation": "Leadbetter MR; Adams SM; Bazzini B; Fatheree PR; Karr DE; Krause KM; Lam BMT; Linsell MS; Nodwell MB; Pace JL; Quast K; Shaw J-P; Soriano E; Trapp SG; Villena JD; Wu TX; Christensen BG; Judice JK Hydrophobic vancomycin derivatives with improved ADME properties: Discovery of telavancin (TD-6424). J. Antibiot 2004, 57, 326\u2013336.", "ArticleIdList": ["15303493"]}, {"Citation": "Bouza E; Burillo A Oritavancin: A novel lipoglycopeptide active against gram-positive pathogens including multiresistant strains. Int. J. Antimicrob. Agents 2010, 36, 401\u2013407.", "ArticleIdList": ["20729040"]}, {"Citation": "Okano A; Isley NA; Boger DL Total syntheses of vancomycin-related glycopeptide antibiotics and key analogues. Chem. Rev 2017, 117, 11952\u201311993.", "ArticleIdList": ["PMC5617763", "28437097"]}, {"Citation": "Okano A; Isley NA; Boger DL Peripheral modifications of [\u03c8[CH2NH]Tpg4]vancomycin with added synergistic mechanisms of action provide durable and potent antibiotics. Proc. Natl. Acad. Sci. U. S. A 2017, 114, E5052\u2013E5061.", "ArticleIdList": ["PMC5495262", "28559345"]}, {"Citation": "Fowler BS; Laemmerhold KM; Miller SJ Catalytic site-selective thiocarbonylations and deoxygenations of vancomycin reveal hydroxyl-dependent conformational effects. J. Am. Chem. Soc 2012, 134, 9755\u20139761.", "ArticleIdList": ["PMC3374881", "22621706"]}, {"Citation": "Han S; Miller SJ Asymmetric catalysis at a distance: Catalytic, site-selective phosphorylation of teicoplanin. J. Am. Chem. Soc 2013, 135, 12414\u201312421.", "ArticleIdList": ["PMC3790668", "23924210"]}, {"Citation": "Pathak TP; Miller SJ Chemical tailoring of teicoplanin with site-selective reactions. J. Am. Chem. Soc 2013, 135, 8415\u20138422.", "ArticleIdList": ["PMC3800266", "23692563"]}, {"Citation": "Ozturk S; Forneris CC; Nguy AKL; Sorensen EJ; Seyedsayamdost MR Modulating OxyB-catalyzed cross-coupling reactions in vancomycin biosynthesis by incorporation of diverse d-Tyr analogues. J. Org. Chem 2018, 83, 7309\u20137317.", "ArticleIdList": ["29806454"]}, {"Citation": "Forneris CC; Seyedsayamdost MR In vitro reconstitution of OxyC activity enables total chemoenzymatic syntheses of vancomycin aglycone variants. Angew. Chem., Int. Ed 2018, 57, 8048\u20138052.", "ArticleIdList": ["29697176"]}, {"Citation": "Baltz RH; Miao V; Wrigley SK Natural products to drugs: Daptomycin and related lipopeptide antibiotics. Nat. Prod. Rep 2005, 22, 717\u2013741.", "ArticleIdList": ["16311632"]}, {"Citation": "Schimana J; Gebhardt K; Holtzel A; Schmid DG; Sussmuth R; Muller J; Pukall R; Fiedler H-P Biosynthetic capacities of actinomycetes arylomycins A and B, new biaryl-bridged lipopeptide antibiotics produced by Streptomyces sp. Tu 6075. I. Taxonomy, fermentation, isolation and biological activities. J. Antibiot 2002, 55, 565\u2013570.", "ArticleIdList": ["12195962"]}, {"Citation": "Roberts TC; Smith PA; Cirz RT; Romesberg FE Structural and initial biological analysis of synthetic arylomycin A2. J. Am. Chem. Soc 2007, 129, 15830\u201315838.", "ArticleIdList": ["18052061"]}, {"Citation": "Liu J; Luo C; Smith PA; Chin JK; Page MGP; Paetzel M; Romesberg FE Synthesis and characterization of the arylomycin lipoglycopeptide antibiotics and the crystallographic analysis of their complex with signal peptidase. J. Am. Chem. Soc 2011, 133, 17869\u201317877.", "ArticleIdList": ["PMC3277211", "21999324"]}, {"Citation": "Liu J; Smith PA; Steed DB; Romesberg F Efforts toward broadening the spectrum of arylomycin antibiotic activity. Bioorg. Med. Chem. Lett 2013, 23, 5654\u20135659.", "ArticleIdList": ["PMC3981466", "24012184"]}, {"Citation": "Peters DS; Romesberg FE; Baran PS Scalable access to arylomycins via C-H functionalization logic. J. Am. Chem. Soc 2018, 140, 2072\u20132075.", "ArticleIdList": ["PMC5817625", "29381350"]}, {"Citation": "Smith PA; Koehler MFT; Girgis HS; Yan D; Chen Y; Chen Y; Crawford JJ; Durk MR; Higuchi RI; Kang J; Murray J; Paraselli P; Park S; Phung W; Quinn JG; Roberts TC; Rouge L; Schwarz JB; Skippington E; Wai J; Xu M; Yu Z; Zhang H; Tan MW; Heise CE Optimized arylomycins are a new class of gram-negative antibiotics. Nature 2018, 561, 189\u2013194.", "ArticleIdList": ["30209367"]}, {"Citation": "Davidovich C; Bashan A; Auerbach-Nevo T; Yaggie RD; Gontarek RR; Yonath A Induced-fit tightens pleuromutilins binding to ribosomes and remote interactions enable their selectivity. Proc. Natl. Acad. Sci. U. S. A 2007, 104, 4291\u20134296.", "ArticleIdList": ["PMC1817833", "17360517"]}, {"Citation": "Novak R Are pleuromutilin antibiotics finally fit for human use? Ann. N. Y. Acad. Sci 2011, 1241, 71\u201381.", "ArticleIdList": ["22191527"]}, {"Citation": "Egger H; Reinshagen H New pleuromutilin derivatives with enhanced antimicrobial activity. II. Structure-activity correlations. J. Antibiot 1976, 29, 923\u2013927.", "ArticleIdList": ["993132"]}, {"Citation": "Rittenhouse S; Biswas S; Broskey J; McCloskey L; Moore T; Vasey S; West J; Zalacain M; Zonis R; Payne D Selection of retapamulin, a novel pleuromutilin for topical use. Antimicrob. Agents Chemother 2006, 50, 3882\u20133885.", "ArticleIdList": ["PMC1635201", "17065625"]}, {"Citation": "Jacobs MR Retapamulin: A semisynthetic pleuromutilin compound for topical treatment of skin infections in adults and children. Future Microbiol. 2007, 2, 591\u2013600.", "ArticleIdList": ["18041900"]}, {"Citation": "Veve MP; Wagner JL Lefamulin: Review of a promising novel pleuromutilin antibiotic. Pharmacotherapy 2018, 38, 935\u2013946.", "ArticleIdList": ["30019769"]}, {"Citation": "Goethe O; Heuer A; Ma X; Wang Z; Herzon SB Antibacterial properties and clinical potential of pleuromutilins. Nat. Prod. Rep 2019, 36, 220\u2013247.", "ArticleIdList": ["29979463"]}, {"Citation": "Murphy SK; Zeng M; Herzon SB A modular and enantioselective synthesis of the pleuromutilin antibiotics. Science 2017, 356, 956\u2013959.", "ArticleIdList": ["PMC7001679", "28572392"]}, {"Citation": "Farney EP; Feng SS; Schafers F; Reisman SE Total synthesis of (+)-pleuromutilin. J. Am. Chem. Soc 2018, 140, 1267\u20131270.", "ArticleIdList": ["PMC5988231", "29323492"]}, {"Citation": "Ma X; Kucera R; Goethe OF; Murphy SK; Herzon SB Directed C-H bond oxidation of (+)-pleuromutilin. J. Org. Chem 2018, 83, 6843\u20136892.", "ArticleIdList": ["29664634"]}, {"Citation": "Pinhey J; Ritchie E; Taylor W The chemical constituents of Himantandra (Galbulimima) species. IV. The structures of himbacine, himbeline, himandravine, and himgravine. Aust. J. Chem 1961, 14, 106\u2013134."}, {"Citation": "Hart DJ; Wu W-L; Kozikowski AP Total syntheses of (+)-himbacine and (+)-himbeline. J. Am. Chem. Soc 1995, 117, 9369\u20139370."}, {"Citation": "Chackalamannil S; Davies RJ; Asberom T; Doller D; Leone D A highly efficient total synthesis of (+)-himbacine. J. Am. Chem. Soc 1996, 118, 9812\u20139813."}, {"Citation": "Chackalamannil S; Xia Y; Greenlee WJ; Clasby M; Doller D; Tsai H; Asberom T; Czarniecki M; Ahn H-S; Boykow G; Foster C; Agans-Fantuzzi J; Bryant M; Lau J; Chintala M Discovery of potent orally active thrombin receptor (protease activated receptor 1) antagonists as novel antithrombotic agents. J. Med. Chem 2005, 48, 5884\u20135887.", "ArticleIdList": ["16161991"]}, {"Citation": "Chelliah MV; Chackalamannil S; Xia Y; Eagen K; Clasby MC; Gao X; Greenlee W; Ahn H-S; Agans-Fantuzzi J; Boykow G; Hsieh Y; Bryant M; Palamanda J; Chan T-M; Hesk D; Chintala M Heterotricyclic himbacine analogs as potent, orally active thrombin receptor (protease activated receptor-1) antagonists. J. Med. Chem 2007, 50, 5147\u20135160.", "ArticleIdList": ["17854166"]}, {"Citation": "Chackalamannil S; Wang Y; Greenlee WJ; Hu Z; Xia Y; Ahn H-S; Boykow G; Hsieh Y; Palamanda J; Agans-Fantuzzi J; Kurowski S; Graziano M; Chintala M Discovery of a novel, orally active himbacine-based thrombin receptor antagonist (SCH 530348) with potent antiplatelet activity. J. Med. Chem 2008, 51, 3061\u20133064.", "ArticleIdList": ["18447380"]}, {"Citation": "Gryka RJ; Buckley LF; Anderson SM Vorapaxar: The current role and future directions of a novel protease-activated receptor antagonist for risk reduction in atherosclerotic disease. Drugs R&D 2017, 17, 65\u201372.", "ArticleIdList": ["PMC5318326", "28063023"]}, {"Citation": "Tamaoki T; Nomoto H; Takahashi I; Kato Y; Morimoto M; Tomita F Staurosporine, a potent inhibitor of phospholipid/ CA++ dependent protein kinase. Biochem. Biophys. Res. Commun 1986, 135, 397\u2013402.", "ArticleIdList": ["3457562"]}, {"Citation": "Karaman MW; Herrgard S; Treiber DK; Gallant P; Atteridge CE; Campbell BT; Chan KW; Ciceri P; Davis MI; Edeen PT; Faraoni R; Floyd M; Hunt JP; Lockhart DJ; Milanov ZV; Morrison MJ; Pallares G; Patel HK; Pritchard S; Wodicka LM; Zarrinkar PP A quantitative analysis of kinase inhibitor selectivity. Nat. Biotechnol 2008, 26, 127\u2013132.", "ArticleIdList": ["18183025"]}, {"Citation": "Kase H; Iwahashi K; Matsuda Y K-252a, a potent inhibitor of protein kinase C from microbial origin. J. Antibiot 1986, 39, 1059\u20131065.", "ArticleIdList": ["3759657"]}, {"Citation": "Gani OA; Engh RA Protein kinase inhibition of clinically important staurosporine analogues. Nat. Prod. Rep 2010, 27, 489\u2013498.", "ArticleIdList": ["20336234"]}, {"Citation": "Caravatti G; Meyer T; Fredenhagen A; Trinks U; Mett H; Fabbro D Inhibitory activity and selectivity of staurosporine derivatives towards protein kinase C. Bioorg. Med. Chem. Lett 1994, 4, 399\u2013404."}, {"Citation": "Fabbro D; Buchdunger E; Wood J; Mestan J; Hofmann F; Ferrari S; Mett H; O\u2019Reilly T; Meyer T Inhibitors of protein kinases: CGP 41251, a protein kinase inhibitor with potential as an anticancer agent. Pharmacol. Ther 1999, 82, 293\u2013301.", "ArticleIdList": ["10454207"]}, {"Citation": "Stone RM; Manley PW; Larson RA; Capdeville R Midostaurin: Its odyssey from discovery to approval for treating acute myeloid leukemia and advanced systemic mastocytosis. Blood Advances 2018, 2, 444\u2013453.", "ArticleIdList": ["PMC5858474", "29487059"]}, {"Citation": "Bourhill T; Narendran A; Johnston RN Enzastaurin: A lesson in drug development. Crit. Rev. Oncol. Hematol 2017, 112, 72\u201379.", "ArticleIdList": ["28325267"]}, {"Citation": "Omura S; Asami Y; Crump A Staurosporine: New lease of life for parent compound of today\u2019s novel and highly successful anti-cancer drugs. J. Antibiot 2018, 71, 688\u2013701.", "ArticleIdList": ["29934602"]}, {"Citation": "Sanchez C; Mendez C; Salas JA Indolocarbazole natural products: Occurrence, biosynthesis, and biological activity. Nat. Prod. Rep 2006, 23, 1007\u20131045.", "ArticleIdList": ["17119643"]}, {"Citation": "Allred TK; Manoni F; Harran PG Exploring the boundaries of \u201cpractical\u201c: De novo syntheses of complex natural product-based drug candidates. Chem. Rev 2017, 117, 11994\u201312051.", "ArticleIdList": ["28603978"]}, {"Citation": "Kuttruff CA; Eastgate MD; Baran PS Natural product synthesis in the age of scalability. Nat. Prod. Rep 2014, 31, 419\u2013432.", "ArticleIdList": ["24337165"]}, {"Citation": "Yu MJ; Zheng W; Seletsky BM; Littlefield BA; Kishi Y Case history: Discovery of eribulin, a halichondrin B analogue that prolongs overall survival in patients with metastatic breast cancer. Annu. Rep. Med. Chem 2011, 46, 227\u2013241."}, {"Citation": "Vila-Farres X; Chu J; Inoyama D; Ternei MA; Lemetre C; Cohen LJ; Cho W; Reddy BV; Zebroski HA; Freundlich JS; Perlin DS; Brady SF Antimicrobials inspired by nonribosomal peptide synthetase gene clusters. J. Am. Chem. Soc 2017, 139, 1404\u20131407.", "ArticleIdList": ["PMC7163397", "28055186"]}, {"Citation": "Cobb RE; Wang Y; Zhao H High-efficiency multiplex genome editing of Streptomyces species using an engineered CRISPR/Cas system. ACS Synth. Biol 2015, 4, 723\u2013728.", "ArticleIdList": ["PMC4459934", "25458909"]}, {"Citation": "Weber T; Charusanti P; Musiol-Kroll EM; Jiang X; Tong Y; Kim HU; Lee SY Metabolic engineering of antibiotic factories: New tools for antibiotic production in actinomycetes. Trends Biotechnol. 2015, 33, 15\u201326.", "ArticleIdList": ["25497361"]}, {"Citation": "Shugrue CR; Miller SJ Applications of nonenzymatic catalysts to the alteration of natural products. Chem. Rev 2017, 117, 11894\u201311951.", "ArticleIdList": ["PMC5742423", "28580785"]}, {"Citation": "Kalkreuter E; Williams GJ Engineering enzymatic assembly lines for the production of new antimicrobials. Curr. Opin. Microbiol 2018, 45, 140\u2013148.", "ArticleIdList": ["29733997"]}, {"Citation": "Wallace S; Balskus EP Opportunities for merging chemical and biological synthesis. Curr. Opin. Biotechnol 2014, 30, 1\u20138.", "ArticleIdList": ["PMC4199929", "24747284"]}, {"Citation": "Patridge E; Gareiss P; Kinch MS; Hoyer D An analysis of FDA-approved drugs: Natural products and their derivatives. Drug Discovery Today 2016, 21, 204\u2013207.", "ArticleIdList": ["25617672"]}]}], "History": [{"Year": "2019", "Month": "4", "Day": "27", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "6", "Day": "23", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "4", "Day": "27", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "5", "Day": "29"}], "PublicationStatus": "ppublish", "ArticleIdList": ["31026161", "NIHMS1592529", "PMC7259720", "10.1021/acs.jmedchem.9b00246"]}}]}